跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 62,055 条关于
“EBV T-cell”
全部
62,055
临床试验
42,574
药物
6,376
机构
313
资讯
12,792
去年
Tabelecleucel Shows Sustained Efficacy in EBV+ PTLD, FDA Decision Expected in January 2025
去年
EBV-Specific T Cell Therapy Shows Survival Benefit in Nasopharyngeal Cancer
去年
Atara Biotherapeutics Secures $16 Million Funding to Advance Tab-cel BLA Approval
去年
EBV-Specific Immune Response Distinct in Multiple Sclerosis Compared to Other Demyelinating Diseases
去年
VANCE Trial: T Cell Therapy Shows Promise in Subgroup of Solid Tumor Patients
2年前
Atara Biotherapeutics Submits BLA for Tabelecleucel to Treat EBV+ PTLD
去年
Cell Therapy Shows Promise for EBV-Driven Post-Transplant Lymphoproliferative Disease
2年前
FDA Grants Priority Review to Tabelecleucel for EBV+ PTLD Treatment
9个月前
Pierre Fabre's Tabelecleucel Shows 47.7% Response Rate in Phase 3 Trial for Rare Post-Transplant Cancer
去年
VANCE Trial: Largest T Cell Therapy Study in Solid Tumors Shows Promise for Precision Immunotherapy in Nasopharyngeal Carcinoma
第 1 页,共 1280 页
上一页
下一页